Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein profile is attenuated by aerobicz exercise training

International Journal of Experimental Pathology

Volumn 89, Issue 5, 2008, Pages 358-366

  Fontana, Karina ^a   Oliveira, Helena Coutinho Franco ^a   Leonardo, Marta Beatriz ^a   Mandarim De Lacerda, Carlos Alberto ^b   Da Cruz Höfling, Maria Alice ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cardiac interstitium; Cardiomyocytes; Lipid profile; Mesterolone; Transgenic murine model; Ventricular hypertrophy

Indexed keywords

ANABOLIC AGENT; ANDROGEN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESTEROLONE; TRIACYLGLYCEROL; TROPONIN T; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AEROBIC EXERCISE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HYPERLIPIDEMIA; HYPERTROPHY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SITTING; TRANSGENIC MOUSE; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL;

ANABOLIC AGENTS; ANIMALS; CHOLESTEROL ESTER TRANSFER PROTEINS; EXERCISE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LIPOPROTEINS; MALE; MESTEROLONE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; RECEPTORS, LDL; TROPONIN T;

EID: 51349094273     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00601.x     Document Type: Article

References (31)

1. Alen M. Rahkila P. (1984) Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor. Int. J. Sports Med. 5, 341 342.
2. Basaria S., Wahlstrom J.T., Dobs A.S. (2001) Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J. Clin. Endocrinol. Metab. 86, 5108 5117.
3. Bauman D.H., Richerson J.T., Britt A.L. (1988) A comparison of body and organ weights, physiologic parameters, and pathologic changes in target organs of rats given combinations of exercise, anabolic hormone, and protein supplementation. Am. J. Sports Med. 16, 397 402.
4. Blair S.N., LaMonte M.J., Nichaman M.Z. (2004) The evolution of physical activity recommendations: how much is enough? Am. J. Clin. Nutr. 79, 913S 920S.
5. Casquero A.C., Berti J.A., Salerno A.G. et al. (2006) Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice. J. Lipid Res. 47, 1526 1534.
6. Cazita P.M., Berti J.A., Aoki C. et al. (2003) Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice. J. Lipid Res. 44, 33 40.
7. Codipilly C.N., Teichberg S., Wapnir R.A. (2006) Enhancement of absorption by gum arabic in a model of gastrointestinal dysfunction. J. Am. Coll. Nutr. 25, 307 312.
8. Dickerman R.D., McConathy W.J., Schaller F. et al. (1996) Cardiovascular complications and anabolic steroids. Eur. Heart J. 17, 1912.
9. Friedewald W.T., Levy R.I., Fredrickson D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499 502.
10. Ganten U., Schroder G., Witt M. et al. (1989) Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J. Hypertens. 7, 721 726.
11. Glazer G. (1991) Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch. Intern. Med. 151, 1925 1933.
12. Gundersen H.J. (1977) Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. 111, 219 227.
13. Halverstadt A., Phares D.A., Wilund K.R. et al. (2007) Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism 56, 444 450.
14. Hartgens F. Kuipers H. (2004) Effects of androgenic-anabolic steroids in athletes. Sports Med. 34, 513 554.
15. Hurley B.F., Seals D.R., Hagberg J.M. et al. (1984) High-density- lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. J. Am. Med. Assoc. 252, 507 513.
16. Kraus W.E., Houmard J.A., Duscha B.D. et al. (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 347, 1483 1492.
17. LaRosa J.C. (1992) Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? Womens Health Issues 2, 102 111.
18. Mandarim-de-Lacerda C.A. (2003) Stereological tools in biomedical research. Ann. Braz. Acad. Sci. 75, 469 486.
19. Marques C.M., Nascimento F.A., Mandarim-de-Lacerda C.A. (2006) Exercise training attenuates cardiovascular adverse remodeling in adult ovariectomized spontaneously hypertensive rats. Menopause 13, 87 95.
20. Nieminen M.S., Ramo M.P., Viitasalo M. et al. (1996) Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur. Heart J. 17, 1576 1583.
21. Rockhold R.W. (1993) Cardiovascular toxicity of anabolic steroids. Annu. Rev. Pharmacol. Toxicol. 33, 497 520.
22. Seals D.R., Hagberg J.M., Hurley B.F. et al. (1984) Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women. JAMA 252, 645 649.
23. Smolka M.B., Zoppi C.C., Alves A.A. et al. (2000) HSP72 as a complementary protection against oxidative stress induced by exercise in the soleus muscle of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1539 R1545.
24. Sullivan M.L., Martinez C.M., Gennis P. et al. (1998) The cardiac toxicity of anabolic steroids. Prog. Cardiovasc. Dis. 41, 1 15.
25. Tagarakis C.V., Bloch W., Hartmann G. et al. (2000a) Anabolic steroids impair the exercise-induced growth of the cardiac capillary bed. Int. J. Sports Med. 21, 412 418.
26. Tagarakis C.V., Bloch W., Hartmann G. et al. (2000b) Testosterone- propionate impairs the response of the cardiac capillary bed to exercise. Med. Sci. Sports Exerc. 32, 946 953.
27. Urhausen A., Albers T., Kindermann W. (2004) Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90, 496 501.
28. Vermeulen A. (2001) Androgen replacement therapy in the aging male - a critical evaluation. J. Clin. Endocrinol. Metab. 86, 2380 2390.
29. Wang M., Tsai B.M., Kher A. et al. (2005) Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 288, H221 H226.
30. Winkler U.H. (1996) Effects of androgens on haemostasis. Maturitas 24, 147 155.
31. Woodiwiss A.J., Trifunovic B., Philippides M. et al. (2000) Effects of an androgenic steroid on exercise-induced cardiac remodeling in rats. J. Appl. Physiol. 88, 409 415.